The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells

British Journal of Haematology

Volumn 133, Issue 3, 2006, Pages 323-330

  Patterson, Angela M ^a   Ford, Isobel ^a   Graham, Audrey ^a   Booth, Nuala A ^a   Greaves, Mike ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anti endothelial antibody; Antiphospholipid antibody; Fibrinolysis

Indexed keywords

FIBRIN; IMMUNOGLOBULIN G; LIPOCORTIN 5; PHOSPHOLIPID ANTIBODY; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; UROKINASE; VON WILLEBRAND FACTOR;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOT LYSIS; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOSIS; UMBILICAL VEIN;

ANNEXIN A5; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; BLOOD COAGULATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIBRIN; FIBRINOLYSIS; HUMANS; IMMUNOENZYME TECHNIQUES; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 33645461251     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.05994.x     Document Type: Article

References (37)

1. Amengual O. Atsumi T. Khamashta M.A. Hughes G.R.V. 1998 The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thrombosis and Haemostasis 79 276 281.
2. Atsumi T. Khamashta M.A. Amengual O. Donohoe S. Mackie I. Ichikawa A. Koike T. Hughes G.R.V. 1998a Binding of anticardiolipin antibodies to protein C via beta2-GP I: a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system. Clinical and Experimental Immunology 112 325 333.
3. Atsumi T. Khamashta M.A. Andujar C. Leandro M.J. Amengual O. Ames P.R. Hughes G.R. 1998b Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. Journal of Rheumatology 25 69 73.
4. Bevers E.M. Janssen M.P. Willems G.M. Zwaal F.A. 2000 No evidence for enhanced thrombin formation through displacement of annexin V by antiphospholipid antibodies. Thrombosis and Haemostasis 83 792 794.
5. Booth N.A. Simpson A.J. Croll A. Bennett B. MacGregor I.R. 1988 Plasminogen activator inhibitor (PAI-1) in plasma and platelets. British Journal of Haematology 70 327 333.
6. Bordron A. Deems M. Levy Y. 1998 The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. Journal of Clinical Investigation 101 2029 2035.
7. Branch D.W. Rodgers G. 1993 Induction of endothelial cells tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. American Journal of Obstetrics and Gynecology 168 206 210.
8. Del Papa N. Guidali L. Spatola L. Bonara P. Borghi M.O. Tincani A. Balestrieri G. Meroni P.L. 1995 Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clinical and Experimental Rheumatology 13 179 185.
9. Donohoe S. Kingdom J.C. Mackie I.J. Birrell S. Quenby S. Jauniaux E. Machin S.J. 2000 Ontogeny of beta2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies. Thrombosis and Haemostasis 84 32 38.
10. Field S.L. Chesterman C.N. Dai Y.P. Hogg P.J. 2001 Lupus antibody bivalency is required to enhance prothrombin binding to phospholipid. Journal of Immunology 166 6118 6125
11. Greaves M. 1999 Antiphospholipid antibodies and thrombosis. Lancet 353 1348 1353.
12. Gris J.C. Ripart-Neveu S. Maugard C. Tailland M.L. Brun S. Courtieu C. Biron C. Hoffet M. Hedon B. Mares P. 1997 Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study. Thrombosis and Haemostasis 77 1096 1103.
13. Hill M.B. Phipps J.L. Malia R.G. Greaves M. Hughes P. 1995 Characterisation and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in the primary antiphospholipid syndrome (APS). Clinical and Experimental Immunology 102 368 372.
14. Hill M.B. Phipps J.C. Hughes P. Greaves M. 1998 Antiendothelial antibodies in primary antiphospholipid syndrome and systemic lupus erythematosus: patterns of reactivity with membrane antigens on microvascular and umbilical venous endothelial cells. British Journal of Haematology 103 416 421.
15. Kuwana M. Matsuura E. Kobayashi K. Okazaki Y. Kaburaki J. Ikeda Y. Kawakami Y. 2005 Binding of beta2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. Blood 105 1552 1557.
16. de Laat B. Derksen R.H. Urbanus R.T. de Groot P.G. 2005 IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105 1540 1545.
17. Lakasing L. Campa J.S. Poston R. Khamashta M.A. Poston L. 1999 Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome. American Journal of Obstetrics and Gynecology 181 180 189.
18. Lindsey N.J. Dawson R.A. Henderson F.I. Greaves M. Hughes P. 1993 Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis-prone patients with systemic lupus erythematosus. British Journal of Rheumatology 32 123 126.
19. MacGregor I.R. MacDonald S. Dawes J. Micklem L.R. James K. 1987 A monoclonal antibody enzyme-linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator. Fibrinolysis 1 247 252.
20. Mackworth-Young C.G. Andreotti F. Harmer I. Loizou S. Pottinger B.E. Pearson J.D. Davies G.J. Maseri A. Walport M.J. 1995 Endothelium-derived haemostatic factors and the antiphospholipid syndrome. British Journal of Rheumatology 34 201 206.
21. Malia R.G. Kitchen S. Greaves M. Preston F.E. 1990 Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. British Journal of Haematology 76 101 107.
22. Matsuda J. Gotch M. Gohchi K. Kawasugi K. Tsukamoto M. Saitol N. 1997 Anti-endothelial cell antibodies to the endothelial hybridoma cell line (Eahy926) in systemic lupus erythematosus patients with antiphospholipid antibodies. British Journal of Haematology 97 227 232.
23. Michiels C. 2003 Endothelial cell functions. Journal of Cellular Physiology 196 430 443.
24. Ogawa H. Zhao D. Dlott J.S. Cameron G.S. Yamazaki M. Hata T. Triplett D.A. 2000 Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities. American Journal of Clinical Pathology 114 619 628.
25. Pierangeli S.S. Harris E.N. 2003 Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus 12 539 545.
26. Pierangeli S.S. Colden-Stanfield M. Liu X. Barker J.H. Anderson G.L. Harris E.N. 1999 Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 99 1997 2002.
27. Pierangeli S.S. Espinola R.G. Liu X. Harris E.N. 2001 Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circulation Research 88 245 250.
28. Rand J.H. 2000 Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome. Journal of Autoimmunity 15 107 111.
29. Rand J.H. Wu X.X. Andree H.A. Lockwood C.J. Guller S. Scher J. Harpel P.C. 1997 Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. New England Journal of Medicine 337 154 160.
30. Rand J.H. Wu X.X. Andree H.A. Ross J.B. Rusinova E. Gascon-Lema M.G. Calandri C. Harpel P.C. 1998 Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a ''lupus procoagulant'' phenomenon. Blood 95 1652 1660.
31. Ritchie H. Robbie L.A. Kinghorn S. Exley R. Booth N.A. 1999 Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrinolysis and is cross-linked to fibrin. Thrombosis and Haemostasis 81 96 103.
32. Scott J.A. Arnold J.J. Currie J.M. Broadfoot C. Davidson M. Kelly K.F. Graham A. Kirkpatrick J.N.P. Greaves M. 2001 No excess of factor V:Q506 genotype, but high prevalence of anticardiolipin antibodies without antiendothelial cell antibodies in retinal vein occlusion in young patients. Ophthalmologica 215 217 221.
33. Short P.E. Williams C.E. Picken A.M. Hill F.G. 1982 Factor VIII related antigen: an improved enzyme immunoassay. Medical Laboratory Sciences 39 351 355.
34. Simantov R. LaSala J.M. Lo S.K. Gharavi A.E. Sammaritano L.R. Salmon J.E. Silverstein R. 1995 Activation of cultured vascular endothelial cells by antiphospholipid antibodies. Journal of Clinical Investigation 96 2211 2219.
35. Tassies D. Espinosa G. Munoz-Rodriguez F.J. Freire C. Cervera R. Monteagudo J. Maragall S. Escolar G. Ingelmo M. Ordinas A. Font J. Reverter J.C. 2000 The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis and Rheumatism 43 2349 2358.
36. Vickers M.A. Greaves M. 2005 The cryptic path from epitope to clot: a story of two domains. Blood 105 1371 1372.
37. Willems G.M. Janssen M.P. Comfurius P. Galli M. Zwaal R.F. Bevers E.M. 2000 Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes. Biochemistry 39 1982 1989.